ALNERVE Trademark

Trademark Overview

On Thursday, March 3, 2022, a trademark application was filed for ALNERVE with the United States Patent and Trademark Office. The USPTO has given the ALNERVE trademark a serial number of 97293176. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 7, 2024. This trademark is owned by Mochida Pharmaceutical Co., Ltd. The ALNERVE trademark is filed in the Medical Instrument Products category with the following description:

Medical implants comprising artificial material in the nature of medical sheets for use in regenerative medicine and in the treatment and repair of nerve injuries
alnerve

General Information

Serial Number97293176
Word MarkALNERVE
Filing DateThursday, March 3, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements

Pseudo MarkAL NERVE
Goods and ServicesMedical implants comprising artificial material in the nature of medical sheets for use in regenerative medicine and in the treatment and repair of nerve injuries

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMochida Pharmaceutical Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type29 - NOT AVAILABLE
AddressTokyo 160-8515
JP
Party NameMochida Pharmaceutical Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type29 - NOT AVAILABLE
AddressTokyo 160-8515
JP

Trademark Events

Event DateEvent Description
Wednesday, December 28, 2022NON-FINAL ACTION E-MAILED
Monday, March 7, 2022NEW APPLICATION ENTERED
Tuesday, March 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 14, 2022ASSIGNED TO EXAMINER
Wednesday, December 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Thursday, March 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 18, 2024SOU EXTENSION 1 FILED
Thursday, January 18, 2024SOU EXTENSION 1 GRANTED
Thursday, January 18, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2024SOU EXTENSION 2 GRANTED
Wednesday, August 7, 2024SOU EXTENSION 2 FILED

Related Keywords

alnerve medical medicine treatment repair injuries nerve regenerative sheets implants comprising